deferoxamine has been researched along with ferric chloride in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (12.24) | 18.7374 |
| 1990's | 20 (40.82) | 18.2507 |
| 2000's | 11 (22.45) | 29.6817 |
| 2010's | 12 (24.49) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aruoma, OI; Cecchini, R; Halliwell, B | 1 |
| Mitrovic, DR; Stankovic, A | 1 |
| Dusel, J; Jedlika, S; Sahasrabudhe, DM | 1 |
| Bor, AM; Yang, YH; Yung, BY | 1 |
| Aruoma, OI; Bell, JD; Bomford, A; Grootveld, M; Halliwell, B; Sadler, PJ | 1 |
| Christoffersen, J; Christoffersen, MR; Thyregod, HC | 1 |
| Farber, JL; Kyle, ME; Miccadei, S; Nakae, D | 1 |
| Fligiel, SE; Johnson, KJ; Till, GO; Ward, PA | 1 |
| Archibald, FS; DeVoe, IW; Simonson, C | 1 |
| Leong, J; Yang, CC | 1 |
| Autenrieth, IB; Bohn, E; Ewald, JH; Heesemann, J | 1 |
| Gross, TJ; Peterson, MW; Walter, ME | 1 |
| Cooke, CL; Ghio, AJ; Hoidal, JR; Kennedy, TP; Miller, MJ; Rao, G | 1 |
| Matsuki, N; Saito, H; Torii, Y | 1 |
| Brunk, UT; Roberg, K; Zdolsek, JM | 1 |
| Brunk, U; Roberg, K; Zdolsek, J; Zhang, H | 1 |
| Brunk, UT; Zhang, H | 1 |
| Buchman, TG; Cobb, JP; DeMeester, SL; Hiramatsu, M; Hotchkiss, RS; Jacob, AK; Karl, IE; Swanson, PE | 1 |
| Cano, J; Machado, A; Matarredona, ER; Santiago, M | 1 |
| Goodner, AP; Jacobson, ES; Nyhus, KJ | 1 |
| Churg, A; Sun, J; Zay, K | 1 |
| Andrei, G; Boelaert, JR; Dieye, T; Farber, CM; Heenen, M; Hermans, P; Lambert, C; Liesnard, C; Lunardi-Yskandar, Y; Noel, JC; Parent, D; Simonart, T; Snoeck, R; Van Vooren, JP | 1 |
| Gendron, R; Grenier, D; Mayrand, D; Sorsa, T; Uitto, VJ | 1 |
| Iijima, M; Imada, C; Ishizuka, M; Okami, Y; Someno, T; Takeuchi, T | 1 |
| Bair, WB; Bowden, GT; Edmonds, A; Kramer-Stickland, K | 1 |
| Gnaiger, E; Oexle, H; Weiss, G | 1 |
| Amoroso, S; Annunziato, L; Catalano, A; Di Renzo, G; Montagnani, S; Secondo, A; Tortiglione, A | 1 |
| Anderson, D; Chua-Anusorn, W; Cole, C; Vives-Bauza, C; Webb, J; Yardley-Jones, A | 1 |
| Armstrong, C; Lees, GJ; Leong, W | 1 |
| Antholine, WE; Jannetto, PJ; Myers, CR | 1 |
| Hong, J; Junxia, X; Ming, Q; Wenfang, C | 1 |
| Alldredge, CD; Levin, LA; Miller, NR; Schlieve, CR | 1 |
| Li, X; Lippmann, M; Salnikow, K | 1 |
| Baakza, A; Dave, BP; Dube, HC | 1 |
| Persson, HL | 1 |
| Caniggia, I; Groenman, FA; Post, M; Rutter, M; Tibboel, D; Wang, J | 1 |
| Basu, S; Kong, Q; Kundu, B; Luo, X; Mohan, ML; Singh, N | 1 |
| Elliott, RL; Head, JF; Jiang, XP | 1 |
| Barbeau, K; Haygood, MG; Mann, EL; Roe, KL | 1 |
| Andrews, D; Gavett, SH; Ghio, AJ; Kodavanti, UP; Richards, JH; Schladweiler, MC; Shannahan, JH | 1 |
| Leake, DS; Satchell, L | 1 |
| Cho, B; Chung, NG; Jang, PS; Jeong, DC; Kim, HK; Lee, DH | 1 |
| Nielsen, VG; Pretorius, E | 1 |
| Choi, SE; Han, SJ; Jung, IR; Jung, JG; Kang, Y; Kim, DJ; Kim, HJ; Lee, KW; Lee, SA | 1 |
| Chen, V; Clemons, KV; Cohen, K; Ferreira, JA; Haagensen, JA; Hsu, JL; Martinez, M; Nazik, H; Penner, JC; Spormann, AM; Stevens, DA | 1 |
| Cai, S; Chen, L; Jiang, S; Shi, Y; Wu, Z; Zhu, R; Zou, X | 1 |
| Elliott, RL; Jiang, XP | 1 |
| Ding, Y; Krafft, P; Li, Q; Wan, W; Wu, G; Yan, F; Zhan, Q; Zhang, JH; Zhang, Y | 1 |
| Chhonker, YS; G-Dayanandan, N; Haney, SL; Holstein, SA; Murry, DJ; Safranek, HR; Talmon, G; Varney, ML; Wiemer, AJ; Wright, DL | 1 |
49 other study(ies) available for deferoxamine and ferric chloride
| Article | Year |
|---|---|
The action of hydrogen peroxide on the formation of thiobarbituric acid-reactive material from microsomes, liposomes or from DNA damaged by bleomycin or phenanthroline. Artefacts in the thiobarbituric acid test.
Topics: Animals; Ascorbic Acid; Bleomycin; Chlorides; Cytochrome P-450 Enzyme Inhibitors; Deferoxamine; DNA; DNA Damage; Edetic Acid; Ferric Compounds; Hydrogen Peroxide; Lipid Peroxidation; Liposomes; Male; Microsomes, Liver; Phenanthrolines; Rats; Thiobarbiturates | 1990 |
Aluminum salts stimulate luminol-enhanced chemiluminescence production by human neutrophils.
Topics: Alum Compounds; Aluminum; Aluminum Chloride; Aluminum Compounds; Azides; Chlorides; Cytochalasin B; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Luminescent Measurements; Luminol; Neutrophils; Pentetic Acid; Sodium Azide | 1991 |
Suppression of delayed type hypersensitivity by desferoxamine.
Topics: Animals; Cell Division; Chlorides; Deferoxamine; Dinitrofluorobenzene; Ferric Compounds; Hypersensitivity, Delayed; Immunosuppression Therapy; Mice; Mice, Inbred BALB C; T-Lymphocytes | 1991 |
Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line.
Topics: Antibodies, Monoclonal; Cell Division; Cell Line; Cell Nucleolus; Cell Nucleus; Chlorides; Deferoxamine; DNA Replication; Ferric Compounds; Fluorescent Antibody Technique; Humans; Leukemia, Promyelocytic, Acute; Nuclear Proteins; Nucleophosmin; Phosphoproteins; RNA Precursors; RNA, Neoplasm; RNA, Ribosomal; Uridine | 1991 |
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.
Topics: Acetates; Bleomycin; Chlorides; Chromatography, High Pressure Liquid; Citrates; Citric Acid; Deferoxamine; Ferric Compounds; Hemochromatosis; Humans; Iron; Magnetic Resonance Spectroscopy; Transferrin; Ultrafiltration | 1989 |
Effects of aluminum(III), chromium(III), and iron(III) on the rate of dissolution of calcium hydroxyapatite crystals in the absence and presence of the chelating agent desferrioxamine.
Topics: Adsorption; Aluminum; Aluminum Chloride; Aluminum Compounds; Chlorides; Chromium; Chromium Compounds; Crystallization; Deferoxamine; Durapatite; Ferric Compounds; Humans; Hydroxyapatites; Nitrates; Solubility; Solutions | 1987 |
Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen.
Topics: Acetaminophen; Animals; Benzoflavones; beta-Naphthoflavone; Carmustine; Catalase; Chlorides; Deferoxamine; Drug Resistance; Ferric Compounds; Ferrous Compounds; Free Radicals; Liver; Male; Mannitol; Methylcholanthrene; Mixed Function Oxygenases; Rats; Rats, Inbred Strains; Superoxide Dismutase | 1987 |
Evidence for a role of hydroxyl radical in immune-complex-induced vasculitis.
Topics: Animals; Apoproteins; Arthus Reaction; Chlorides; Deferoxamine; Dimethyl Sulfoxide; Drug Evaluation, Preclinical; Ferric Compounds; Ferrous Compounds; Free Radicals; Hydroxylation; Immune Complex Diseases; Lactoferrin; Male; Quaternary Ammonium Compounds; Rats; Rats, Inbred Strains; Specific Pathogen-Free Organisms; Vasculitis | 1984 |
Comparison of iron binding and uptake from FeCl3 and Fe-citrated by Neisseria meningitidis.
Topics: Biological Transport, Active; Chlorides; Deferoxamine; Energy Metabolism; Ferric Compounds; Iron; Kinetics; Neisseria meningitidis; Temperature | 1981 |
Production of deferriferrioxamines B and E from a ferroverdin-producing Streptomyces species.
Topics: Chlorides; Cobalt; Culture Media; Deferoxamine; Ferric Compounds; Ferrous Compounds; Iron Chelating Agents; Nitroso Compounds; Peptides, Cyclic; Phenols; Streptomyces | 1982 |
Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages.
Topics: Actins; Animals; Base Sequence; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Chlorides; Cytokines; Deferoxamine; Female; Ferric Compounds; Gene Expression Regulation; Interleukins; Iron Chelating Agents; Kinetics; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Molecular Sequence Data; RNA, Messenger; Tumor Necrosis Factor-alpha; Yersinia enterocolitica | 1995 |
Asbestos directly increases lung epithelial permeability.
Topics: Asbestos; Cell Line; Chlorides; Deferoxamine; Dextrans; Epithelial Cells; Epithelium; Ferric Compounds; Humans; L-Lactate Dehydrogenase; Lung; Mannitol; Permeability; Time Factors | 1993 |
Complexation of iron cation by sodium urate crystals and gouty inflammation.
Topics: Chemotaxis, Leukocyte; Chlorides; Complement Activation; Crystallization; Deferoxamine; Ferric Compounds; Gout; Humans; In Vitro Techniques; Inflammation; Iron; Kinetics; Leukotriene B4; Neutrophils; Uric Acid | 1994 |
Effects of iron and deferoxamine on cisplatin-induced emesis: further evidence for the role of free radicals.
Topics: Animals; Chlorides; Cisplatin; Deferoxamine; Drug Synergism; Female; Ferric Compounds; Free Radicals; Injections, Intraperitoneal; Shrews; Vomiting | 1993 |
Visualization of iron in cultured macrophages: a cytochemical light and electron microscopic study using autometallography.
Topics: Animals; Cells, Cultured; Chemical Precipitation; Chlorides; Deferoxamine; Ferric Compounds; Ferritins; Histocytochemistry; Hydrogen-Ion Concentration; Iron; Lysosomes; Mice; Mice, Inbred BALB C; Microscopy, Electron; Peritoneal Cavity; Silver; Sulfides | 1993 |
H2O2-mediated damage to lysosomal membranes of J-774 cells.
Topics: Acridine Orange; Adenosine Triphosphate; Animals; Cell Death; Chlorides; Cysteine Proteinase Inhibitors; Deferoxamine; Endocytosis; Ferric Compounds; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Intracellular Membranes; Kinetics; Leucine; Lymphoma, Large B-Cell, Diffuse; Lysosomes; Mice; Microscopy, Electron; Trypan Blue; Tumor Cells, Cultured | 1993 |
Alloxan cytotoxicity is highly potentiated by plasma membrane- and lysosomal-associated iron--a study on a model system of cultured J-774 cells.
Topics: Alloxan; Animals; Cell Line; Cell Membrane; Cell Membrane Permeability; Cell Survival; Chlorides; Cysteine; Deferoxamine; Ferric Compounds; Hydrogen Peroxide; Kinetics; Lymphoma, Large B-Cell, Diffuse; Lysosomes; Mice; Models, Biological; Time Factors; Tumor Cells, Cultured | 1993 |
Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism.
Topics: Cell Survival; Cells, Cultured; Chlorides; Deferoxamine; Drug Carriers; Endothelium, Vascular; Ferric Compounds; Free Radicals; Hot Temperature; Humans; Iron Chelating Agents; Kinetics; Microcirculation; Models, Biological; Oxyquinoline; Phenanthrolines; Quaternary Ammonium Compounds; Reactive Oxygen Species; Umbilical Veins | 1997 |
Involvement of iron in MPP+ toxicity in substantia nigra: protection by desferrioxamine.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Chlorides; Deferoxamine; Dopamine; Ferric Compounds; Male; Microdialysis; Neuroprotective Agents; Rats; Rats, Wistar; Substantia Nigra | 1997 |
Ferrous iron uptake in Cryptococcus neoformans.
Topics: Biological Transport; Chlorides; Copper; Cryptococcus neoformans; Deferoxamine; Edetic Acid; Ferric Compounds; Ferrous Compounds; Iron Radioisotopes; Kinetics | 1998 |
Cigarette smoke increases amosite asbestos fiber binding to the surface of tracheal epithelial cells.
Topics: Animals; Asbestos, Amosite; Chlorides; Deferoxamine; Dust; Epithelial Cells; Ferric Compounds; Glutathione; Microscopy, Electron, Scanning; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Smoke; Smoking; Trachea | 1998 |
Iron as a potential co-factor in the pathogenesis of Kaposi's sarcoma?
Topics: Carcinogens; Cell Division; Chelating Agents; Chlorides; Deferoxamine; Ferric Compounds; Fibroblast Growth Factor 2; Humans; Iron; Nitrilotriacetic Acid; Sarcoma, Kaposi; Skin Neoplasms; Tumor Cells, Cultured | 1998 |
Effect of microbial siderophores on matrix metalloproteinase-2 activity.
Topics: Bacteria; Calcium Chloride; Chelating Agents; Chlorides; Chromium; Collagen; Connective Tissue; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Extracellular Matrix; Ferric Compounds; Ferrichrome; Gelatinases; Humans; Hydroxybenzoates; Indicators and Reagents; Iron Chelating Agents; Macromolecular Substances; Matrix Metalloproteinase 2; Metalloendopeptidases; Periodontitis; Phenylmercuric Acetate; Phenylpyruvic Acids; Piperazines; Rosaniline Dyes; Siderophores; Sodium Dodecyl Sulfate; Sulfhydryl Reagents | 1999 |
IC202A, a new siderophore with immunosuppressive activity produced by Streptoalloteichus sp. 1454-19. I. Taxonomy, fermentation, isolation and biological activity.
Topics: Actinomycetales; Amides; Animals; Cell Line; Cell Survival; Chlorides; Deferoxamine; Fermentation; Ferric Compounds; Hydroxamic Acids; Immunosuppressive Agents; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred C3H; Mitogens; Siderophores | 1999 |
Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation.
Topics: Antioxidants; Cell Line; Chlorides; Deferoxamine; Ferric Compounds; Humans; Iron Chelating Agents; Reactive Oxygen Species; Transcription Factor AP-1; Transcriptional Activation; Ultraviolet Rays | 1999 |
Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation.
Topics: Aconitate Hydratase; Cell Line; Chlorides; Citric Acid Cycle; Deferoxamine; Energy Metabolism; Ferric Compounds; Glycolysis; Humans; Iron; Iron Deficiencies; Mitochondria; Oxidative Phosphorylation; Oxygen Consumption; Succinate Dehydrogenase | 1999 |
Sodium nitroprusside prevents chemical hypoxia-induced cell death through iron ions stimulating the activity of the Na+-Ca2+ exchanger in C6 glioma cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amiloride; Animals; Bepridil; Calcium; Calcium Channel Blockers; Cell Hypoxia; Cell Survival; Chelating Agents; Chlorides; Deferoxamine; Enzyme Activation; Extracellular Space; Ferric Compounds; Ferricyanides; Fluoresceins; Glioma; L-Lactate Dehydrogenase; Molsidomine; Nitric Oxide; Nitroprusside; Sodium; Sodium Channels; Sodium-Calcium Exchanger; Staining and Labeling; Tetrodotoxin; Tumor Cells, Cultured; Vasodilator Agents | 2000 |
Effect of iron salts, haemosiderins, and chelating agents on the lymphocytes of a thalassaemia patient without chelation therapy as measured in the comet assay.
Topics: Australia; beta-Thalassemia; Blood Transfusion; Chelating Agents; Chlorides; Comet Assay; Deferiprone; Deferoxamine; DNA Damage; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hemosiderin; Humans; Lymphocytes; Male; Pyridones; Reference Values; Spleen | 2000 |
Comparative effects of metal chelating agents on the neuronal cytotoxicity induced by copper (Cu+2), iron (Fe+3) and zinc in the hippocampus.
Topics: Animals; Cell Survival; Chelating Agents; Chlorides; Copper Sulfate; Cytotoxins; Deferoxamine; Edetic Acid; Ethylenediamines; Ferric Compounds; Hippocampus; Male; Neurons; Phenanthrolines; Rats; Rats, Wistar; Zinc | 2001 |
Cytochrome b(5) plays a key role in human microsomal chromium(VI) reduction.
Topics: Adenosine Diphosphate; Chlorides; Chromium; Cytochromes b5; Deferoxamine; Ferric Compounds; Humans; Liposomes; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Proteolipids; Recombinant Proteins | 2001 |
Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease.
Topics: Animals; Apomorphine; Behavior, Animal; Caudate Nucleus; Chlorides; Deferoxamine; Disease Models, Animal; Dopamine; Drug Administration Routes; Female; Ferric Compounds; Iron; Iron Chelating Agents; Parkinsonian Disorders; Putamen; Rats; Rats, Sprague-Dawley | 2003 |
Pathophysiology of the optic neuropathy associated with Friedreich ataxia.
Topics: Animals; Animals, Newborn; Anisoles; Cell Death; Cells, Cultured; Chlorides; Deferoxamine; Ferric Compounds; Ferrous Compounds; Fluorescent Dyes; Frataxin; Friedreich Ataxia; Iron Chelating Agents; Iron-Binding Proteins; Mitochondria; Optic Nerve Diseases; Oxidative Stress; Pyrones; Rats; Rats, Long-Evans; Reactive Oxygen Species; Retinal Ganglion Cells | 2003 |
Effect of nickel and iron co-exposure on human lung cells.
Topics: Air Pollutants; Blotting, Western; Carbon; Cell Cycle Proteins; Chlorides; Coal Ash; Deferoxamine; Epithelial Cells; Ferric Compounds; Humans; Hypoxia; Interleukin-8; Intracellular Signaling Peptides and Proteins; Iron Chelating Agents; Lung; Nickel; Particulate Matter | 2004 |
Chemical nature, ligand denticity and quantification of fungal siderophores.
Topics: Biological Assay; Carboxylic Acids; Chlorides; Deferoxamine; Dose-Response Relationship, Drug; Epinephrine; Ferric Compounds; Fungi; Hydroxamic Acids; Iron; Ligands; Siderophores; Spectrophotometry | 2004 |
Iron-dependent lysosomal destabilization initiates silica-induced apoptosis in murine macrophages.
Topics: Animals; Apoptosis; Cattle; Cell Line; Cell Membrane; Cell Survival; Chlorides; Deferoxamine; DNA Fragmentation; Enzyme Inhibitors; Ferric Compounds; Iron Chelating Agents; Lysosomes; Macrophages; Membrane Potentials; Mice; Mitochondria; NADPH Oxidases; Onium Compounds; Serum; Silicon Dioxide | 2005 |
Effect of chemical stabilizers of hypoxia-inducible factors on early lung development.
Topics: Amino Acids, Dicarboxylic; Animals; Chlorides; Cobalt; Deferoxamine; Dose-Response Relationship, Drug; Embryo, Mammalian; Epithelial Cells; Ferric Compounds; Hypoxia-Inducible Factor 1; In Vitro Techniques; Indoles; Lung; Mice; Morphogenesis; Neovascularization, Physiologic; Pyrroles; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Topics: Aged; Animals; Brain; Cell Line, Tumor; Cell Membrane Permeability; Chlorides; Deferoxamine; Endopeptidase K; Ferric Compounds; Ferritins; Humans; Iron; Iron Deficiencies; Mice; Middle Aged; Oxidation-Reduction; Prion Diseases; Protein Conformation; PrPC Proteins; PrPSc Proteins; Tissue Extracts | 2007 |
Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cation Transport Proteins; Cell Line, Tumor; Chlorides; Deferoxamine; Female; Ferric Compounds; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Oligonucleotides, Antisense; Receptors, Transferrin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2010 |
Acquisition of iron by Trichodesmium and associated bacteria in culture.
Topics: Chlorides; Cyanobacteria; Deferoxamine; Ferric Compounds; Hydroxamic Acids; Iron; Siderophores | 2012 |
Transcriptional activation of inflammasome components by Libby amphibole and the role of iron.
Topics: Animals; Asbestos, Amphibole; Bronchoalveolar Lavage Fluid; Chlorides; Cytokines; Deferoxamine; Ferric Compounds; Inflammasomes; Lung; Male; Rats; Rats, Inbred SHR; RNA, Messenger; Siderophores; Transcriptional Activation | 2012 |
Oxidation of low-density lipoprotein by iron at lysosomal pH: implications for atherosclerosis.
Topics: alpha-Tocopherol; Atherosclerosis; Chlorides; Deferoxamine; Ferric Compounds; Ferrous Compounds; Hydrogen-Ion Concentration; Iron Chelating Agents; Lipoproteins, LDL; Lysosomes; Pentetic Acid | 2012 |
Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoates; Cell Line, Tumor; Chlorides; Crosses, Genetic; Deferasirox; Deferoxamine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; fas Receptor; Female; Ferric Compounds; Gene Expression Regulation, Leukemic; Iron; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Leukemia L1210; Liver; Lymphoma, T-Cell; Mice; Mice, Inbred Strains; Neoplasm Proteins; Triazoles; Tumor Burden | 2013 |
Iron-enhanced coagulation is attenuated by chelation: thrombelastographic and ultrastructural analysis.
Topics: Blood Coagulation; Chlorides; Deferoxamine; Ferric Compounds; Fibrinogen; Humans; Iron Chelating Agents; Microscopy, Electron, Scanning; Platelet-Rich Plasma; Thrombelastography; Tissue Plasminogen Activator | 2014 |
Involvement of iron depletion in palmitate-induced lipotoxicity of beta cells.
Topics: Animals; Apoferritins; Benzoates; Cell Death; Cell Line, Tumor; Chlorides; Deferasirox; Deferoxamine; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Ferric Compounds; Ferrous Compounds; Gene Expression Regulation; Humans; Insulin-Secreting Cells; Iron Chelating Agents; Iron Deficiencies; JNK Mitogen-Activated Protein Kinases; Palmitic Acid; Rats; Receptors, Transferrin; Signal Transduction; Transcription Factor CHOP; Transferrin; Triazoles | 2015 |
Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm.
Topics: Antifungal Agents; Aspergillus fumigatus; Benzoates; Biofilms; Chlorides; Deferasirox; Deferiprone; Deferoxamine; Ferric Compounds; Iron; Iron Chelating Agents; Microbial Sensitivity Tests; Plankton; Pyridones; Spores, Fungal; Tetrazolium Salts; Triazoles | 2015 |
Effectiveness of deferoxamine on ferric chloride-induced epilepsy in rats.
Topics: Animals; Anticonvulsants; Blotting, Western; Brain; Chlorides; Deferoxamine; Disease Models, Animal; Drug Evaluation, Preclinical; Electroencephalography; Epilepsy; Ferric Compounds; Ferritins; Iron; Magnetic Resonance Imaging; Male; Random Allocation; Rats, Sprague-Dawley; Siderophores; Superoxide Dismutase; Transferrin | 2017 |
Decreased Iron in Cancer Cells and Their Microenvironment Improves Cytolysis of Breast Cancer Cells by Natural Killer Cells.
Topics: Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Chlorides; Deferoxamine; Ferric Compounds; Ferritins; Gene Expression Regulation, Neoplastic; Humans; Iron; Killer Cells, Natural; Nitric Oxide; Oxidoreductases; RNA, Messenger; Siderophores; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2017 |
Targeting Germinal Matrix Hemorrhage-Induced Overexpression of Sodium-Coupled Bicarbonate Exchanger Reduces Posthemorrhagic Hydrocephalus Formation in Neonatal Rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Cerebral Hemorrhage; Cerebrospinal Fluid; Chlorides; Choroid Plexus; Cognition; Deferoxamine; Disease Models, Animal; Ferric Compounds; Hydrocephalus; Injections, Intraventricular; Iron Regulatory Protein 1; Iron Regulatory Protein 2; Motor Activity; Rats, Sprague-Dawley; RNA, Small Interfering; RNAi Therapeutics; Siderophores; Sodium-Bicarbonate Symporters | 2018 |
Tropolone-induced effects on the unfolded protein response pathway and apoptosis in multiple myeloma cells are dependent on iron.
Topics: Animals; Apoptosis; Cell Cycle; Cell Proliferation; Chlorides; Deferoxamine; Female; Ferric Compounds; Ferrous Compounds; Humans; Iron; Iron Chelating Agents; Mice; Multiple Myeloma; Quaternary Ammonium Compounds; Receptors, Transferrin; Siderophores; Tropolone; Tumor Cells, Cultured; Unfolded Protein Response; Xenograft Model Antitumor Assays | 2019 |